Study types
- article 18
- other 4
- preprint 2
- dataset 1
- meta-analysis 1
Condition tags
- endometriosis 14
- adenomyosis 7
- infertility 5
- dysmenorrhea 4
- endometrioma 2
- disambig:endometritis 1
- chronic_pelvic_pain 1
- dyspareunia 1
Top journals
Frequent coauthors
- Hongyan Tian 3
- Jin Hee Kim 2
- Dongmei Lin 2
- He Cai 2
- Caiqi Ma 2
- Charlotte D. Owens 2
- Guifang Yu 2
- David F. Archer 2
- D.A. Bradley 2
- Juanzi Shi 2
dataset
2024
Objectives: To identify an optimal magnetic resonance imaging (MRI)-based classification for the severity of adenomyosis and explore the factors associated with disease severity (dysmenorrhea or menorrhagia). Design and Participants: Severa…
review
2023
OBJECTIVE: To evaluate the risk of recurrence and reintervention after uterine-sparing treatment options for symptomatic adenomyosis, including adenomyomectomy, uterine artery embolization (UAE), and image-guided thermal ablation. DATA SOUR…
meta-analysis
2023
OBJECTIVE: To evaluate the risk of recurrence and reintervention after uterine-sparing treatment options for symptomatic adenomyosis, including adenomyomectomy, uterine artery embolization (UAE), and image-guided thermal ablation. DATA SOU…
other
2022
OBJECTIVE: Endometriosis is a common benign disease in women of reproductive age. Qu's formula (QUF) is a patented Chinese herbal medicine for treating endometriosis that has been proven to be effective in treating and preventing the recurr…
article
2022
This retrospective cohort study explored the morphological features of chronic endometritis (CE) and pregnancy outcomes during in vitro fertilization (IVF) in women with CE (429) at Yantai Yuhuangding Hospital between January 2017 and Septe…
other
2022
BACKGROUND: Intrauterine insemination (IUI) treatment is recommended in subfertile women with AFS/ASRM stage I/II endometriosis. However, the efficacy of IUI in women with ovarian endometriomas with tubal patency is uncertain. We explored t…
other
2022
BACKGROUND: Endometriosis (EMS) is a "tumour-like" gynaecological disease with distant metastasis, and studies have shown that EMS can induce distant metastasis through vascular vessels, but the driving factors and their mechanism are not c…
preprint
2022
Abstract Background Endometriosis (EMS) is a "tumor-like" gynecological disease with distant metastasis, and studies have shown that EMS can carry out distant metastasis through vascular vessels, but the driving factor and its mechanism is …
article
2021
OBJECTIVE: To determine if coexisting adenomyosis limits the efficacy of elagolix, an oral gonadotropin-releasing hormone antagonist, with hormonal add-back therapy in reducing heavy menstrual bleeding in women with uterine fibroids. DESIGN…
preprint
2021
Abstract Background : Intrauterine insemination (IUI) treatment is recommended in subfertile women with AFS/ASRM stage I/II endometriosis. However, the efficacy of IUI in women with ovarian endometriomas with tubal patency is uncertain. We …
article
2021
BACKGROUND: Elagolix is an oral, gonadotropin-releasing hormone (GnRH) receptor antagonist, that significantly reduces dysmenorrhea and non-menstrual pelvic pain (NMPP) in women with moderate to severe endometriosis-associated pain. METHODS…
article
2021
other
2021
BACKGROUND: Endometriosis, the presence of active endometrial tissue outside the lining membrane of the uterine cavity, is a common disease in women of childbearing age. The ectopic endometrium has some characteristics of tumor tissue, incl…
article
2020
INTRODUCTION: Evaluate the efficacy of elagolix with add-back therapy on menstrual blood loss (MBL) and safety in women with uterine fibroids (UF), heavy menstrual bleeding (HMB) and adenomyosis. METHODS: Pooled data from two investigationa…
article
2018
INTRODUCTION: To evaluate the long-term effect of elagolix, an oral, non-peptide GnRH antagonist, on bone mineral density (BMD) in two 6-month (M) extension studies (Elaris EM-III and IV) of the pivotal, 6M, phase 3 studies (12M overall tre…
article
2017
article
2012
Objective:To explore intrauterine device on Mirena in the treatment of uterine glands of myopathy clinical efficacy and side effects.Methods:observed 48 cases in patients with uterine gland myopathy placed on Mirena before and after dysmeno…
article
2012
Objective To observe Danzhuxiaoyifang combined with laparoscopy on serum IL-8 of infertile patients with mild endometriosis.Methods 50 patients were divided into 2 groups,the treat group was given Traditional Chinese Medicine after laparosc…
article
2012
article
2010
Objective To study the features of pathologic morphology and the expressions of p53,cyclin E,CD44_(V6)in clear cell carcinoma,and their relationship with patients' survival.Methods Twenty-four patients with clear cell carcinoma of ovary (CC…
article
2010
article
2009
Objective:To explore the expression of tumor necrosis factor(TNF)and vascular endothelial growth factors(VEGF)in both serum and peritoneal fluid of endometriosis patients and to evaluate the functions of them in the pathogenesis of endometr…
article
2008
OBJECTIVE: To explore the mechanism of inhibitory effect of SLW on estrogen production by endometrial cells of endometriosis. METHOD: After the model of eutopic primary cultured endometrial cells of endometiosis and hysteromyoma in vitro wa…
article
2003
Purpose To observe the curative effect of acupoint application on endometriosis.Methods Application of Qili San, a Chinese patent medicine, to a body point Shenque (CV 8) plus moxibustion with moxa sticks was used to treat 31 patients with …
article
2001
Objective To evaluate the ultrasonographic features and the types of adenomyosis and to analyze the reasons of misdiagnosis. Methods To analyze retrospectively ultrasonographic feature of 196 cases with adenomyosis and compared with the res…